A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling
Petros Christopoulos, Michal Harel, Coren Lahav, Itamar Sela, Nili Dahan, Niels Reinmuth, Ina Koch, Alona Zer, Mor Moskovitz, Adva Levy-Barda, Michal Lotem, Hovav Nechushtan, Rivka Katzenelson, Abed Agbarya, Mahmoud Abu-Amna, Maya Gottfried, Ella Tepper, Christine B. Ambrosone, Ido Wolf, Yanyan Lou, Raya Leibowitz, Adam P. Dicker, David P. Carbone, David Gandara
medRxiv 2022.12.01.22282769; doi: https://doi.org/10.1101/2022.12.01.22282769